Inhibikase Therapeutics, Inc. Common Stock IKT
$1.55
-7.19%
at last close
Dividend
Inhibikase Therapeutics, Inc. Common Stock (IKT) does not currently pay a regular dividend, based on the most recent data available. Companies that retain earnings instead of paying dividends often reinvest in growth; check the financials page for how Inhibikase Therapeutics, Inc. Common Stock deploys its earnings.
Key Stats
- Last Close
- $1.55
- Market Cap
- $233.02 million
- 52-Week Range
- $1.33 – $2.61
- Average Volume
- 620K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.